VIA
NTUS

Vident Investment Advisory’s Natus Medical Inc NTUS Stock Holding History

Vident Investment Advisory’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-14,340
Closed -$610K – 1173
2015
Q2 		$610K Buy
14,340
+768
+6% +$30.6K 0.08% 368
2015
Q1 		$536K Buy
+13,572
New +$500K 0.11% 367

Other funds holding NTUS

EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
HCM
Hodges Capital Management Dallas, Texas $1.51B AUM 85.85% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vident Investment Advisory's NTUS Position: Q3 2015 in Review

Vident Investment Advisory sold out of Natus Medical Inc (NTUS) in Q3 2015, closing a stake of 14,340 shares — an estimated $610K sold.

Vident Investment Advisory first reported a position in NTUS in Q1 2015 and held it in 2 quarters. The position peaked at $610K in Q2 2015. 192 funds tracked by Wall St. Rank hold NTUS as of Q3 2015.

  • Vident Investment Advisory reported no remaining Natus Medical Inc position as of Q3 2015 after selling out during the quarter.
  • Vident Investment Advisory sold 14,340 Natus Medical Inc shares in Q3 2015, an estimated $610K.
  • Vident Investment Advisory first reported a position in Natus Medical Inc in Q1 2015 and held it in 2 quarters.
  • Vident Investment Advisory's Natus Medical Inc position peaked at $610K in Q2 2015.
  • 192 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2015.

Based on Vident Investment Advisory's 13F filing for Q3 2015, filed 26 Oct 2015.